logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Timothy F Herpin

This inventor holds 15 USPTO granted patents and 2 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, Aventis Pharmaceuticals Inc.. Active years: 2003-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy F Herpin. Retrieved from https://idiyas.com/inventor/timothy-f-herpin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 86.7


Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 117(Granted Patents)


Company Filing History:

goldMedal14 out of 3,742 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal1 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents

Years Active: 2003-2011

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 8053450 - [object Object] (2011-11-08),
2. 7951793 - Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method (2011-05-31),
3. 7674828 - [object Object] (2010-03-09),
4. 7507757 - Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method (2009-03-24),
5. 7470712 - [object Object] (2008-12-30),
6. 7388021 - [object Object] (2008-06-17),
7. 7279485 - Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method (2007-10-09),
8. 7138526 - Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives (2006-11-21),
9. 7067525 - Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same (2006-06-27),
10. 7041692 - Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus (2006-05-09),
11. 6979691 - Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same (2005-12-27),
12. 6875782 - Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method (2005-04-05),
13. 6846838 - Ureido-substituted aniline compounds useful as serine protease inhibitors (2005-01-25),
14. 6713487 - Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same (2004-03-30),
15. 6596747 - Compounds derived from an amine nucleus and pharmaceutical compositions comprising same (2003-07-22),

Title: Innovations and Contributions of Timothy F. Herpin

Introduction

Timothy F. Herpin is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that target specific receptors in the human body. With a total of 15 patents to his name, Herpin's work has the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents, one invention focuses on novel amino-benzazoles and their analogues, which serve as selective inhibitors of the human P2Y receptor. This invention also encompasses various pharmaceutical compositions and methods for treating diseases that respond to modulation of P2Y receptor activity. Another significant patent involves substituted heterocyclic derivatives that are useful as antidiabetic and antiobesity agents, providing compounds with specific structural characteristics.

Career Highlights

Throughout his career, Timothy F. Herpin has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bristol-Myers Squibb Company and Aventis Pharmaceuticals Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in drug formulation and therapeutic applications.

Collaborations

Timothy has collaborated with esteemed colleagues, including R. Michael Lawrence and George C. Morton. These partnerships have fostered innovation and have been instrumental in advancing their shared research goals.

Conclusion

Timothy F. Herpin's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…